AI videolaryngoscope aims to make intubation safer and cheaper

NCT ID NCT07592702

Knowledge-focused Sponsor: Federal University of Pelotas Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, low-cost 3D-printed videolaryngoscope that uses artificial intelligence to help doctors insert breathing tubes in critically ill patients. Researchers will compare it to standard devices in 120 ICU patients across four hospitals in Brazil. The goal is to see if the AI-enhanced tool improves success rates and safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: AI-integrated 3D-printed videolaryngoscope
What this could lead to: If successful, this could provide a cheaper, AI-assisted tool for safer intubation in emergency and ICU settings.
What could go wrong: This is an early-phase trial with only 120 patients, so results may not apply broadly. The device is new and untested in real clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2027

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient: * Age ≥18 years. * Both sexes. * Clinical indication for orotracheal intubation. Physician: * Both sexes. * Working in emergency or ICU settings. * Minimum of one year of experience in laryngoscopy and/or orotracheal intubation. Exclusion Criteria: Patient: * Clinically unstable or with contraindications to participation in experimental research. * Significant airway malformations. * Previously intubated or with a functioning tracheostomy. * Pregnant. Physicians: * On vacation or leave during the study period. * Orthopedic, visual, or cognitive limitations that impair participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Orotracheal intubation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Orotracheal intubation

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

4 sites. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

AI videolaryngoscope aims to make intubation safer and cheaper

What the study statuses mean